ARVO View By Katrina Norfleet
ARVO View By Katrina Norfleet
With the annual meeting of the American Academy of Ophthalmology (AAO) next month in New Orleans within sight, plan to attend the ARVO/AAO Combined Symposium, titled “Recent Advances in Management of Diabetic Retinopathy.”
With the paradigm shift in treatments demonstrated in recent trials, clinicians can now implement these therapies and increase the ability to improve visual acuity in patients with diabetic retinopathy.
A panel of experts, moderated by Jennifer Irene Lim, MD, FARVO, will focus on potential roles of new diagnostic technology, improved medical management, and the use of anti-vascular endothelial growth factor (VEGF) agents for the various stages of diabetic retinopathy.
Here’s who is speaking:
Interested in a career in research? Attend “YO ARVO! Navigating a career as a clinician-scientist” to learn and network with senior clinician-scientists.
This session, sponsored by ARVO’s Members-in-Training Committee and AAO Young Ophthalmologist Committee, offers an opportunity to get burning questions answered about research careers.
Join peers at this event on Sunday, Nov. 12, 2:30 to 3:30 p.m. in the YO Lounge, Room 222, at the New Orleans Ernest N. Morial Convention Center.
Finally, while at the AAO meeting, stop by the ARVO exhibit booth 3513, meet ARVO staffers, and receive information about new products, services, and upcoming meetings that will benefit your clinical career.
Translational Vision Science and Technology (TVST) received its first impact factor from the Journal Citation Reports (JCR) from Clarivate Analytics. At 2.221, this impact factor places TVST favorably among established journals in the ophthalmological field.
Launched in 2012, TVST is the newest journal published by ARVO. The online-only, open-access journal covers a broad spectrum of work from clinicians and scientists, and invites authors to submit multidisciplinary research that bridges the gap between basic research and clinical care. Visit tvst.arvojournals.org.
Investigative Ophthalmology & Visual Science (IOVS) is accepting papers for a special issue on dry age-related macular degeneration (AMD). Milam Brantley Jr., MD, PhD, of Vanderbilt Eye Institute and James Handa, MD, of Wilmer Eye Institute are serving as guest editors.
The deadline to submit a manuscript is March 1, 2018. The issue will open early in 2018, as the first accepted papers are ready to publish.
In addition to original peer-reviewed research articles on AMD, the issue will feature several invited papers on epidemiology, inflammation, lipids, oxidative stress, big data analysis, imaging, and stem cell possibilities.
For more information, contact IOVS Editorial Coordinator Marco Stoutamire at mstoutamire@arvo.
Abstract submission for the ARVO 2018 annual meeting in Honolulu is open through Friday, Dec. 1.
ARVO accepts submissions of original research for poster and paper presentation at the global meeting of more than 11,000 including clinical researchers and clinicians. For more information, visit arvo.org/am/abstract.
ARVO members who would like to discuss a common scientific interest (controversial issue, understanding a technique, new technological advance, etc.) may submit a proposal for a Special Interest Group (SIG) meeting at the 2018 annual meeting by the same Dec. 1 deadline as abstract submissions.
Visit arvo.org/am for more information.
Director of communications
Association for Research in Vision and Ophthalmology